Decitabine exerted synergistic effects with oxaliplatin in colorectal cancer cells with intrinsic resistance to decitabine

Hosokawa, M; Tanaka, S; Ueda, K; Iwakawa, S; Ogawara, K

Hosokawa, M (reprint author), Kobe Pharmaceut Univ, Dept Pharmaceut, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019; 509 (1): 249

Abstract

Epigenetic modifiers such as decitabine (DAC), a DNA methyltransferase inhibitor, have the potential benefit of combination therapy with conventional ......

Full Text Link